Former CM Prithviraj Chavan slams ICMR announcement that vaccine will be ready by August 15 with reasoning
Mumbai: Former Chief Minister and senior Congress leader Prithviraj Chavan on Saturday targeted Prime Minister Narendra Modi over the timing of the launch of the COVAXIN vaccine on August 15 by Indian council of Medical Research (ICMR). “Is this an attempt to make a big announcement by Prime Minister Modi from the Red Fort?” he asked.
As the number of corona virus (COVID-19) victims in the country is increasing day by day, the last few days have seen a huge increase in the number of corona positive cases. In such a scenario, the first all-India vaccine for corona virus, COVAXIN, is expected to be launched on August 15, the ICMR stated in a statement.
The vaccine has been developed by Bharat Biotech in association with ICMR and the National Institute of Virology (NIV). According to a letter issued by ICMR, registration for human testing will start from July 7. After that, if all the tests are passed properly, it is expected that the vaccine would be launched by August 15.
Meanwhile, Chavan fired a salvo at the Prime Minister over the announcement. He has alleged that the government is using the reported development of the vaccine to divert public attention from the government’s alleged failures.
“ICMR’s claim that the vaccine for COVID-19 will be ready by August 15 is untrue. Against the backdrop of lock-down, collapsed economy, disgrace in the Galvan Valley, is it a ploy to allow Modi to make a big announcement from the Red Fort? The health minister should give an explanation”, said Chavan.
Announcement of vaccine preparation on Monday
Bharat Biotech had on Monday announced the development of COVAXIN vaccine on corona. Together with ICMR and the National Institute of Virology (NIV), they successfully developed the first corona vaccine in India.
Subsequently, the Drug Controller General of India, the Central Drugs Standards Control Organization (CDSCO), the Ministry of Health and Family Welfare gave permission for the commencement of Phase 1 and Phase 2 human medical tests.
“The SARS-COV-2 strain was isolated at NIV in Pune and later transferred to Bharat Biotech. The vaccine is also developed at Bharat Biotech’s BSL-3 (Bio-Safety Level 3) High Containment Facility in Genome Valley, Hyderabad, the company said in a statement.